Switching Osteoporosis Patients Currently on Oral Bisphosphonate to Zoledronic Acid
Status:
Completed
Trial end date:
2005-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess bone mineral density in patients switching from an
oral bisphosphonate to zoledronic acid, compared to those staying on the oral bisphosphonate.